habs-hd

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

1. 60/100

   Plasma p-tau217 and cognitive impairment: Evaluating biomarker equity across racial/ethnic groups in HABS-HD

   ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Alzheimer's & dementia (Amsterdam, Netherlands) · 2026-01-01 · Biomarkers

   Plasma p-tau217 is robustly associated with cognitive impairment across diverse populations with varying thresholds, highlighting the need for population-specific calibration to support equitable biomarker implementation.

   • Biomarkers
   • Health Equity
2. 60/100

   Characterization of plasma AT(N) biomarkers among a racial and ethnically diverse community-based cohort: an HABS-HD study

   ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Alzheimer's & dementia (New York, N. Y.) · 2025-01-01 · Biomarkers

   Our findings indicate differential relationships between comorbidities (demographic, medical, diagnostic) across NHB, Hispanic, and NHW participants.

   • Biomarkers
   • Health Equity
3. 53/100

   Comorbidities Incorporated to Improve Prediction for Prevalent Mild Cognitive Impairment and Alzheimer's Disease in the HABS-HD Study

   ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Journal of Alzheimer's disease : JAD · 2023-01-01 · Biomarkers

   Combining feature-selected biomarkers and comorbidities enhances prediction performance, while feature selection optimizes their integration.

   • Early Stage

All topic tags with their study counts